UBS analyst Kevin Caliendo raised the firm’s price target on Cardinal Health (CAH) to $160 from $150 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH: